Introduction to PBMs

Infographics

PBMs Will Save Health Plan Sponsors And Consumers More Than $1 Trillion On Prescription Drugs

Talking Points

Pharmacy Benefit Manager (PBM) Basics: Innovative Tools and Techniques

Policies To Reduce Prescription Drug Costs In 2021

Studies

Visante The Return on Investment (ROI) on PBM Services

Pharmacy Benefit Managers (PBMs): Generating Savings for Plan Sponsors and Consumers

PBM Industry Competition

Infographics

The PBM Marketplace is Highly Competitive

Number of Pharmacies, Openings/Closings

Infographics

Nationwide, More Independent Pharmacies Opened in 2020

PBM Value/Savings

Infographics

PBMs Save Employers & Patients $625 Per Enrollee Per Year on Prescription Drug Costs

PBMs Save Employers & Patients $100 Billion Per Year on Prescription Drug Costs

Employers Are Overwhelmingly Satisfied With Their PBMs

PBMs Will Save Health Plan Sponsors And Consumers More Than $1 Trillion On Prescription Drugs

PBMs Are Trusted Business Partners For Healthcare Payers

PBM Solutions For Patients And Payers

PBMs Save Consumers About $962 Per Person, Per Year

PBMs Save On Prescription Costs For Patients And Plans

PCMA Members Administer Majority Of Prescription Fills In Every State

PBMs Use Competition To Negotiate Lower Net Costs For Hepatitis C Treatments

Talking Points

PBMs Are Innovating to Increase Affordable Access to Insulin

Studies

Increased Costs Associated With Proposed State Legislation Impacting PBM Tools

Pharmacy Benefit Managers (PBMs): Generating Savings for Plan Sponsors and Consumers

Manufacturer anti-competitive behavior/abuses

Infographics

Brand Drug Manufacturers’ Anti-Competitive Behavior: Patent Thickets

Cost-Sharing Caps Don’t Solve The Problem Of High Drug Prices

PBMs Support Policies To Lower Drug Costs And Increase Quality Of Care

Brand Drug Manufacturer Lawsuits Prevent Biosimilar Launches In The U.S.

New Data Shows That Manufacturer Drug Price Increases Are Unrelated To PBM Negotiated Rebates

Talking Points

Cost-sharing Caps Don’t Solve the Problem of High Drug Prices

Studies

Increasing Prices Set by Drugmakers Not Correlated With Rebates

Reconsidering Drug Prices, Rebates, and PBMs

Stay Connected with PCMA!